ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers. The startup, which centers on improving treatment outcomes of dogs and cats with cancer first, now aims to expand its precision medicine technology for human oncology applications. “The […]
© 2023 TechCrunch. All rights reserved. For personal use only.
ImpriMed, a California-based precision medicine startup, builds AI-powered dog cancer treatment technology that helps veterinarians identify the most suitable drugs for individual canine and feline blood cancers. The startup, which centers on improving treatment outcomes of dogs and cats with cancer first, now aims to expand its precision medicine technology for human oncology applications. “The
© 2023 TechCrunch. All rights reserved. For personal use only. Read More TechCrunch AI, Biotech & Health, biotech startups, cancer treatment, ImpriMed, Pets, SoftBank Ventures Asia, south korea
